Showing all 4 results
Amiloride & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized strength ratio, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amiloride (as HCl) USP/BP 5 mg The Potassium Guard: Prevents the loss of potassium, protecting against heart arrhythmias and muscle weakness. Hydrochlorothiazide USP/BP 50 mg The Volume Reducer: Excretes excess sodium and water to reduce the load on the heart and vessels. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure a consistent diuretic effect over a full 24-hour cycle. Benzthiazide & Triamterene Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Benzthiazide USP/BP 25 mg The Thiazide Payload: The primary driver for sodium and water excretion to lower blood pressure. Triamterene USP/BP 50 mg The Potassium Guardian: Physically prevents the loss of Potassium (K+) during the diuretic process. Excipients Proprietary Matrix Bio-Balance System: Engineered to ensure synchronized dissolution of both active APIs for maximum clinical synergy. Sirolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Nano-crystal Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute kinetic stability of the sensitive macrolide API.
Active Ingredient Strength Primary Clinical Function Sirolimus USP/Ph.Eur. 1 mg Global Standard: Base titration unit for precise blood-level adjustments in renal transplant recipients. Sirolimus USP/Ph.Eur. 2 mg Standard daily maintenance dose (following initial loading protocols). Excipients Macrogol / Microcrystalline Cellulose / Sucrose / Povidone / Magnesium Stearate Solid Dispersion Carrier / Diluent / Binder (Engineered to drastically enhance the systemic absorption of the highly insoluble API) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 100 (Optimized specifically for strict, life-long transplant adherence regimens).
Torsemide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, providing dosage flexibility for both mild hypertension and severe renal failure.
Active Ingredient Strength Primary Clinical Use Torsemide USP/Ph.Eur. 5 mg / 10 mg Standard maintenance therapy for mild-to-moderate congestive heart failure and essential hypertension. Torsemide USP/Ph.Eur. 20 mg Acute diuresis for severe hepatic cirrhosis and advanced heart failure exacerbations. Torsemide USP/Ph.Eur. 100 mg High-dose therapy specifically reserved for patients with severe chronic renal failure (CRF) and massive fluid overload. Excipients Lactose Monohydrate / Crospovidone / Magnesium Stearate Diluent / Superdisintegrant / Lubricant (Engineered for immediate, predictable gastric dissolution)
